TSS
DCOY icon

Two Sigma Securities’s Decoy Therapeutics DCOY Stock Holding History

Two Sigma Securities’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-85
Closed -$11.6K – 2027
2025
Q1 		$11.6K Buy
+85
New +$24.7K ﹤0.01% 1207
2024
Q1 		– Sell
-9
Closed -$8.45K – 3588
2023
Q4 		$8.45K Buy
+9
New +$8.98K ﹤0.01% 2841
2022
Q4 		– Hold
0
– -$2K – 3199
2022
Q3 		– Hold
0
– – – 2517
2022
Q2 		– Hold
0
– – – 2128
2022
Q1 		– Hold
0
– – – 2063
2021
Q3 		– Sell
-1
Closed -$31K – 1912
2021
Q2 		$31K Buy
+1
New +$44.5K ﹤0.01% 1431
2019
Q4 		– Sell
-1
Closed -$119K – 2615
2019
Q3 		$119K Buy
+1
New +$341K ﹤0.01% 1928
2019
Q2 		– Hold
0
– -$18K – 2388
2019
Q1 		– Hold
0
– – – 1682
2018
Q3 		– Hold
0
– -$13K – 2977
2018
Q2 		– Hold
0
– – – 2574

Other funds holding DCOY

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $5.4B AUM 28.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Securities's DCOY Position: Q2 2025 in Review

Two Sigma Securities sold out of Decoy Therapeutics (DCOY) in Q2 2025, closing a stake of 85 shares — an estimated $11.6K sold.

Two Sigma Securities first reported a position in DCOY in Q3 2019 and held it in 4 quarters. The position peaked at $119K in Q3 2019. 8 funds tracked by Wall St. Rank hold DCOY as of Q2 2025.

  • Two Sigma Securities reported no remaining Decoy Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 85 Decoy Therapeutics shares in Q2 2025, an estimated $11.6K.
  • Two Sigma Securities first reported a position in Decoy Therapeutics in Q3 2019 and held it in 4 quarters.
  • Two Sigma Securities's Decoy Therapeutics position peaked at $119K in Q3 2019.
  • 8 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.